Withdrawals due to adverse events · patients with Raynaud's phenomenon
Calcium channel blockers showed no clear difference in number of withdrawals due to adverse events Number of participants… compared with placebo (low certainty).
1 finding from 1 review
Serious adverse events Number of participants who died or withdrew and were hospitalized as a result of adverse effects of treatment · patients with Raynaud's phenomenon
1 finding from 1 review
Death or dependency at end of · people with acute ischemic stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death at the end of treatment · people with acute ischemic stroke
Other calcium antagonists showed no clear difference in death at the end of treatment compared with placebo (low certainty).
1 finding from 1 review
Death at the end of · people with acute ischemic stroke
Other calcium antagonists showed no clear difference in death at the end of compared with placebo (low certainty).
1 finding from 1 review
Recurrence of stroke at the end of · people with acute ischemic stroke
1 finding from 1 review
Adverse events during treatment period · people with acute ischemic stroke
Other calcium antagonists showed no clear difference in adverse events during treatment period compared with placebo (low certainty).
1 finding from 1 review
Hypotension · people with acute ischemic stroke
Other calcium antagonists showed no clear difference in hypotension during treatment period compared with placebo (low certainty).
1 finding from 1 review
Systolic blood pressure · people with acute ischemic stroke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pre‐eclampsia · pregnant women and their infants..
1 finding from 1 review
Gestational diabetes · pregnant women and their infants..
It is very uncertain whether vitamin D + calcium + other vitamins and minerals changes gestational diabetes compared with calcium + other vitamins and minerals (but no vitamin D) (very low certainty).
1 finding from 1 review
Maternal adverse event: hypercalcaemia · pregnant women and their infants..
1 finding from 1 review
Adverse events ‐ Hypercalciuria · pregnant women and their infants..
1 finding from 1 review
Preterm birth · pregnant women and their infants..
Vitamin D + calcium + other vitamins and minerals showed no clear difference in preterm birth (less than 37 weeks' gestation) compared with calcium + other vitamins and minerals (but no vitamin D) (low certainty).
1 finding from 1 review
Low birthweight · pregnant women and their infants..
Vitamin D + calcium + other vitamins and minerals showed no clear difference in low birthweight (less than 2500 g) compared with calcium + other vitamins and minerals (but no vitamin D) (low certainty).
1 finding from 1 review
Systolic blood pressure · People who may be at risk for primary hypertension
2 findings from 1 review
Diastolic blood pressure · People who may be at risk for primary hypertension
1 finding from 1 review
Systolic blood pressure. Dose less than 1000 mg a day (range of · People who may be at risk for primary hypertension
1 finding from 1 review
Systolic blood pressure. Dose between 1000 mg a day and less than 1500 mg a day · People who may be at risk for primary hypertension
1 finding from 1 review
Systolic blood pressure. Dose 1500 mg a day or more (range of · People who may be at risk for primary hypertension
1 finding from 1 review